The mammalian target of rapamycin (mTOR) complex 1 (mTORC1) suppresses the initiation of autophagy by phosphorylating ULK1, and mTOR activity is upregulated in Alzheimer disease, Parkinson disease, and Huntington disease2,3. Here, MTOR is linked to early-onset autosomal dominant Alzheimer disease.